Barrier function of the nasal mucosa in health and type-2 biased airway diseases

被引:100
|
作者
Zhang, N. [1 ]
Van Crombruggen, K. [1 ]
Gevaert, E. [1 ]
Bachert, C. [1 ,2 ]
机构
[1] Ghent Univ Hosp, Dept Otorhinolaryngol, Upper Airway Res Lab, Ghent, Belgium
[2] Karolinska Inst, CLINTEC, Div ENT Dis, Stockholm, Sweden
关键词
allergic rhinitis; chronic rhinosinusitis with nasal polyps; eosinophil extracellular traps; immune response; nasal epithelial barrier; INNATE LYMPHOID-CELLS; CHRONIC RHINOSINUSITIS PATIENTS; STAPHYLOCOCCUS-AUREUS; EPITHELIAL BARRIER; ALLERGIC RHINITIS; DIMINISHED LEVELS; IMMUNE-RESPONSES; DENDRITIC CELLS; BETA-DEFENSINS; ION-TRANSPORT;
D O I
10.1111/all.12809
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
The mucosal lining of the upper airways represents the outer surface of the body to the ambient air and its contents and is prepared for it as the first line of defense. Apart from the well-described physical barrier and the mucociliary clearance, a variety of systems, including the airway microbiome, antimicrobial proteins, damage-associated molecular patterns, innate lymphoid cells, epithelial-derived cytokines and chemokines, and finally the adaptive immune system, as well as eosinophils as newly appreciated defense cells form different levels of protection against and response to any possible intruder. Of interest especially for allergic airway disease, mucosal germs might not just elicit a classical Th1/Th17-biased inflammatory response, but may directly induce a type-2 mucosal inflammation. Innovative therapeutic interventions may be possible at different levels also; however, whether modulations of the innate or adaptive immune responses will finally be more successful, and how the correction of the adaptive immune response might impact on the innate side, will be determined in the near future.
引用
收藏
页码:295 / 307
页数:13
相关论文
共 33 条
  • [1] Epithelial Barrier in the Nasal Mucosa, Related Risk Factors and Diseases
    Zhang, Rong
    Zhang, Lan
    Li, Peishan
    Pang, Kaiyun
    Liu, Huixia
    Tian, Li
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2023, 184 (05) : 481 - 501
  • [2] Type 2 inflammation in asthma and other airway diseases
    Maspero, Jorge
    Adir, Yochai
    Al-Ahmad, Mona
    Celis-Preciado, Carlos A.
    Colodenco, Federico D.
    Giavina-Bianchi, Pedro
    Lababidi, Hani
    Ledanois, Olivier
    Mahoub, Bassam
    Perng, Diahn-Warng
    Vazquez, Juan C.
    Yorgancioglu, Arzu
    ERJ OPEN RESEARCH, 2022, 8 (03)
  • [3] The potential roles and mechanisms of Chitinase-3-like-1 in the pathogenesis of type 2-biased airway diseases
    Zhou, Yian
    Liu, Zheng
    Liu, Yang
    CLINICAL IMMUNOLOGY, 2023, 257
  • [4] Cystatin SN in type 2 inflammatory airway diseases
    Yan, Bing
    Ren, Yimin
    Liu, Chang
    Shu, Linping
    Wang, Chengshuo
    Zhang, Luo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (05) : 1191 - +
  • [5] Symbiotic microbiomeStaphylococcus aureusfrom human nasal mucus modulates IL-33-mediated type 2 immune responses in allergic nasal mucosa
    Jeon, Yung Jin
    Gil, Chan Hee
    Won, Jina
    Jo, Ara
    Kim, Hyun Jik
    BMC MICROBIOLOGY, 2020, 20 (01)
  • [6] Modulating nasal barrier function and tissue remodeling in inflammatory diseases: the role of ginseng and its bioactive compounds
    Piazzetta, Giovanna Lucia
    Lobello, Nadia
    Pelaia, Corrado
    Mariaimmacolata, Preiano
    Lombardo, Nicola
    Chiarella, Emanuela
    TISSUE BARRIERS, 2025,
  • [7] Systemic barrier dysfunction in type 2 inflammation diseases: perspective in the skin, airways, and gastrointestinal tract
    Meng, Juan
    Xiao, Hao
    Xu, Feng
    She, Xueke
    Liu, Chuntao
    Canonica, Giorgio Walter
    IMMUNOLOGIC RESEARCH, 2025, 73 (01)
  • [8] Barrier Impairment and Type 2 Inflammation in Allergic Diseases: The Pediatric Perspective
    Ghezzi, Michele
    Pozzi, Elena
    Abbattista, Luisa
    Lonoce, Luisa
    Zuccotti, Gian Vincenzo
    D'Auria, Enza
    CHILDREN-BASEL, 2021, 8 (12):
  • [9] Exploring the immunopathology of type 2 inflammatory airway diseases
    Albloushi, Shaimaa
    Al-Ahmad, Mona
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [10] IL-25: Regulator of Type 2 Inflammation in Allergic Nasal Mucosa
    Liao, Shumin
    Tan, Kai Sen
    Bi, Mingmin
    Liao, Wei
    Chen, Yuan
    Hong, Haiyu
    CURRENT TREATMENT OPTIONS IN ALLERGY, 2019, 6 (04) : 350 - 362